Deep brain stimulation shows promise for treatment-resistant depression
Deep brain stimulation (DBS) is back in the news, after an Emory University speaker reviewed evidence for its efficacy in treatment-resistant depression at the APA meeting. Patients remain awake during the procedure, and some report an immediate lift.
The FDA has approved DBS for Parkinsonism and then for tremor caused by a number of neurologic disorders.
Investigators are trying the procedure on a host of other illnesses, and more headlines are sure to appear.
Related searches
Helen Mayberg (the speaker at APA)
Brodmann area 25 (the affected cortical region).
Evidence-based Articles
Ponder this: A recent meta-analysis by Johns Hopkins researchers finds a “high rate of suicide” among Parkinson’s patients treated with DBS.
You have the option to purchase full text by clicking the link “View Medline
Clinical Trials
You can learn from information about clinical trials where the procedure is being tested.
